After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Clover Health Investments Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Healthcare Plans industry. The current market capitalization of Clover Health Investments Corp is $1.74B. A total of 15.78 million shares were traded on the day, compared to an average of 8.20M shares.
In the most recent transaction, Reynoso Jamie L. sold 19,789 shares of CLOV for 2.58 per share on Jul 03 ’25. After the transaction, the CEO, Medicare Advantage now owns 3,308,539 company shares. In a previous transaction on Jul 07 ’25, Reynoso Jamie L. sold 2,012 shares at 2.85 per share. CLOV shares that CEO, Medicare Advantage owns now total 3,297,821.
Among the insiders who bought shares, Wai Conrad acquired of 225,000 shares on Jul 08 ’25 at a per-share price of $3.25. In another insider transaction, JAMIE REYNOSO bought 2,012 shares at $2.56 per share on Jul 07 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CLOV has a high of $4.87 and a low of $1.50.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CLOV’s latest balance sheet shows that the firm has $615.25M in Cash & Short Term Investments as of fiscal 2021. There were $27.83M in debt and $372.62M in liabilities at the time. Its Book Value Per Share was $0.70, while its Total Shareholder’s Equity was $539.32M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CLOV is Buy with a score of 4.00.
